Pacemaker Market To Reach $7.7 Billion By 2030 | CAGR: 5.7%

Pacemaker Market Growth & Trends

The global pacemaker market size is expected to reach USD 7.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 5.7% from 2025 to 2030. The market is experiencing steady growth, driven by advancements in medical technology and an increasing global demand for heart rhythm management solutions. Technological innovations, such as leadless pacemakers, smaller devices, and improved battery life, have significantly enhanced the effectiveness and convenience of pacemaker implantation. Integrating remote monitoring capabilities has also improved patient care by allowing healthcare providers to track pacemaker function and patient health remotely, reducing hospital visits. In November 2024, Europe witnessed its first single-chamber, wireless cardiac pacemaker implantation at Bern University Hospital. This procedure, led by experts from the UAE, underscores the country's position as a leader in medical innovation and its commitment to training regional healthcare professionals.

The market benefits from a greater focus on treating heart conditions such as bradycardia, arrhythmias, and heart failure. As cardiovascular diseases remain one of the leading causes of death globally, the need for reliable and effective pacing devices continues to rise. Pacemakers are increasingly seen as a critical solution for improving patient outcomes, leading to their widespread adoption in hospitals and outpatient centers. With continuous advancements in pacemaker technology and a growing demand for cardiac care, the market is expected to maintain strong growth in the coming years. In November 2023, MedStar Washington Hospital Center became one of the first institutions in the U.S. to offer the Aveir DR Leadless Pacemaker System for patients with abnormally slow heart rates.

 Request a free sample copy or view report summary: Pacemaker Market Report

Pacemaker Market Report Highlights

• The implantable pacemaker segment dominated the product category in 2024 with 68.0% of the market share due to its proven effectiveness in treating heart rhythm disorders and widespread adoption in clinical practice.

• In 2024, the bradycardia segment accounted for a substantial share of 27.5% by application owing to the high prevalence of bradycardia, particularly among aging populations.

• In terms of end use, the hospital segment dominated in 2024 due to the advanced healthcare infrastructure and specialized care available in hospital settings. Outpatient facilities are anticipated to grow at the fastest CAGR owing to the increasing adoption of minimally invasive procedures and shorter recovery times.

• North America held the largest share of 43.4% of the global market due to advanced healthcare infrastructure, high healthcare spending, and early adoption of innovative pacemaker technologies.

• Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period due to rising cardiovascular disease prevalence, improving healthcare access, and increasing healthcare investments in the region.

• The competition features key players implementing strategies like product launches, distribution agreements, and strategic partnerships, which have greatly expanded their market share.

Pacemaker Market Segmentation

Grand View Research has segmented the global pacemaker market based on product, application, end use, and region:

Pacemaker Product Outlook (Revenue, USD Million, 2018 - 2030)

• External pacemakers

• Single Chamber

• Dual Chamber

• Implantable pacemakers

  • Conventional

    • Single Chamber

    • Dual Chamber

    • Biventricular Chamber

  • Leadless

    • Single Chamber

    • Dual Chamber

Pacemaker Application Outlook (Revenue, USD Million, 2018 - 2030)

• Bradycardia

• Acute Myocardial Infarction

• Arrhythmias

• Atrial Fibrillation

• Heart Block

• Long QT Syndrome

• Congestive Heart Failure

• Others

Pacemaker End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Outpatient Facilities

Pacemaker Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Pacemaker Market

• OSYPKA MEDICAL

• Boston Scientific Corporation

• Zoll Medical Corporation, an Asahi Kasei Group Company

• Medtronic

• BIOTRONIK SE & Co. KG

• MicroPort Scientific Corporation

• MEDICO S.R.L.

• Shree Pacetronix Ltd.

• Abbott

• OSCOR Inc

• Lepu Medical Technology (Beijing) Co., Ltd.